Activin A Solution, Human, Recombinant
Activin A is an important protein on regenerative medicine research because of maintaining pluripotency of hPSCs and helping differentiation to cardiomyocyte. This product obtained written confirmation of raw material eligibility from the PMDA: the pharmaceutical regulatory and review agency of the Japanese Ministry of Health, Labor and Welfare.
*Manufactured by AJINOMOTO CO., INC
Feature
- Free from components of animal origin
- Frozen solution; easy to use
- High purity and activity
- High batch homogeneity
Comparsion with competitors
Nacalai Tesque | Company A | Company B | Company C | |
---|---|---|---|---|
Host cell | E.coli | E.coli | CHO cell | Human cell |
Endotoxin | < 0.01 EU/μg | NA | < 0.01 EU/μg | < 0.1 EU/μg |
Purity | ≥ 97% (SDS-PAGE) | ≥ 97% (SDS-PAGE, HPLC) | > 95% (SDS-PAGE) | ≥ 95% (SDS-PAGE) |
Bio activity*1 | WHO standard*2 ED50 ± 50% (K562) | ED50 ≤ 2.0 ng/mL (MPC-11) | ED50: 0.2 - 1.2 ng/mL (K562) | ED50: 0.5 - 5 ng/mL (MPC-11) |
Form | Frozen liquid (0.1 mg/mL) | Lyophilized | Lyophilized | Lyophilized |
*1: Measured by its ability to include hemoglobin expression in K562 human chronic myelogenous leukemia cells
*2: NIBSC code, 91/626
Product form
Concentration* | 0.1 mg/mL with HPLC |
---|---|
N-terminal | Gly-Leu-Glu |
Buffer | 50 mM sodium acetate buffer, pH 4.6 |
Endotoxin | < 0.01 EU/μg (LAL method) |
Sterilization | Sterilized with 0.2 μm filter |
*As concentration of 1 mg packing size, #18585-81, may differ on each lot, contact us if you need information.
Reference
Takebe, T. et al. Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells. Cell Rep. 2017, 21(10), p. 2661-2670.
Note
Need an optimization of concentration for the first time.
Download
Activin A Solution, Human, Recombinant(PDF 432 kB)